STOCK TITAN
  1. Home
  2. Sec-filings
  3. LH
  4. [Form 4] LABCORP HOLDINGS INC. Insider Trading Activity

Labcorp (LH) EVP converts RSUs to stock and withholds shares for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Sandra D. van der Vaart, EVP Corporate Affairs, reported multiple stock transactions involving restricted stock units (RSUs) and related tax withholding. On February 6, 2026, 387 RSUs were converted into the same number of Labcorp common shares at an exercise price of $0, and 101 shares were disposed of at $277.20 per share to cover tax withholding, leaving 2,589.4864 common shares directly owned. On February 7, 2026, a further 353 RSUs were converted into common stock at $0, increasing direct ownership to 2,942.4864 shares. On February 9, 2026, 93 shares were disposed of at $274.01 per share for tax withholding, with 2,849.4864 common shares held directly afterward. The filing shows 1,870 RSUs held after the February 6 transaction and 1,517 RSUs after the February 7 transaction, each RSU representing the right to receive one Labcorp common share. The share totals include 29.8173 shares acquired under the company’s 2025 Employee Stock Purchase Plan.

Positive

  • None.

Negative

  • None.
Insider van der Vaart Sandra D
Role EVP, Corporate Affairs
Type Security Shares Price Value
Tax Withholding Common Stock 93 $274.01 $25K
Exercise Restricted Stock Unit 353 $0.00 --
Exercise Common Stock 353 $0.00 --
Exercise Restricted Stock Unit 387 $0.00 --
Exercise Common Stock 387 $0.00 --
Tax Withholding Common Stock 101 $277.20 $28K
Holdings After Transaction: Common Stock — 2,849.486 shares (Direct); Restricted Stock Unit — 1,517 shares (Direct)
Footnotes (1)
  1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Amount includes 29.8173 shares acquired on December 31, 2025 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan. Stock withholding to satisfy tax withholding obligations. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. This number reflects the aggregate number of Restricted Stock Units held by the reporting person. The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
van der Vaart Sandra D
(Last) (First) (Middle)
531 SOUTH SPRING STREET
(Street)
BURLINGTON NC 27215
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Corporate Affairs
3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/06/2026 M 387 A (1) 2,690.4864(2) D
Common Stock 02/06/2026 F(3) 101 D $277.2 2,589.4864 D
Common Stock 02/07/2026 M 353 A (1) 2,942.4864 D
Common Stock 02/09/2026 F(3) 93 D $274.01 2,849.4864 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 02/06/2026 M 387 (4) (4) Common Stock 387 $0 1,870(5) D
Restricted Stock Unit (1) 02/07/2026 M 353 (6) (6) Common Stock 353 $0 1,517(5) D
Explanation of Responses:
1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. Amount includes 29.8173 shares acquired on December 31, 2025 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan.
3. Stock withholding to satisfy tax withholding obligations.
4. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
5. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
6. The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Kathryn W. Kyle, Attorney-in-Fact for Sandra D. van der Vaart 02/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Labcorp (LH) report for EVP Corporate Affairs?

Labcorp’s EVP Corporate Affairs, Sandra D. van der Vaart, reported RSU conversions into common stock and related tax-withholding share disposals in early February 2026. The transactions involved several hundred shares at prices around $277.20 and $274.01 per share, as disclosed in the Form 4.

How many Labcorp (LH) restricted stock units did the EVP convert in February 2026?

The executive converted 387 restricted stock units on February 6, 2026 and 353 restricted stock units on February 7, 2026. Each RSU represents the right to receive one share of Labcorp common stock, so the conversions produced the same number of common shares in each case.

How many Labcorp (LH) shares were withheld for taxes in these Form 4 transactions?

The Form 4 shows 101 shares of Labcorp common stock disposed of at $277.20 on February 6, 2026 and 93 shares at $274.01 on February 9, 2026. Footnotes state these dispositions were stock withholding to satisfy tax withholding obligations on vested RSUs.

What is Sandra D. van der Vaart’s Labcorp (LH) share ownership after these transactions?

After the reported transactions, the executive directly owned 2,849.4864 Labcorp common shares, as shown following the February 9, 2026 disposition. The filing also reports 1,517 restricted stock units remaining, representing rights to receive the same number of additional common shares in the future.

How do Labcorp (LH) restricted stock units work in this Form 4 filing?

Each Labcorp restricted stock unit in this filing represents a contingent right to receive one share of common stock. Footnotes explain the RSU grants vest in three equal annual installments beginning on specific February dates, after which vested units can convert into common shares at an exercise price of $0.

Does the Form 4 mention Labcorp (LH) shares from the Employee Stock Purchase Plan?

Yes. A footnote states the reported common stock amount includes 29.8173 shares acquired on December 31, 2025 under the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan, indicating part of the executive’s share ownership comes from that employee purchase program.